The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1501
Drugs for Bipolar Disorder
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Bipolar disorder is characterized by intermittent episodes of mania and/or depression.1 Even with maintenance treatment, recurrences of manic or (more frequently) depressive episodes are common. Some of the drugs and dosages recommended here have not been approved by the FDA for use in bipolar disorder.

TREATMENT OF MANIA — Second-generation antipsychotics, lithium, and valproate are effective for treatment of acute manic episodes.2 Both lithium and valproate may take days to weeks to have a full therapeutic effect; treatment of an acute manic episode with these agents generally requires addition of an antipsychotic drug.

TREATMENT OF DEPRESSION — The second-generation antipsychotics quetiapine and lurasidone and the combination of olanzapine and fluoxetine have been shown to be effective in treating bipolar ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Bipolar Disorder
Article code: 1501a
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian